Clinical Results of Asqelio™ EDOF Toric Soft Hydrophobic Intraocular Lens After Cataract Surgery
Launched by AST PRODUCTS, INC. · Jan 18, 2024
Trial Information
Current as of July 03, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients 50 years old or more submitted to bilateral cataract surgery and implanted with Asqelio EDOF toric IOL, with cylinder value of 0.0 D.
- • Patients signing informed consent
- • Transparent media except for the cataracts
- • Potential postoperatoria visual acuity of 20/25 or better
- Exclusion Criteria:
- • Preoperative corneal astigmatism greater than 1.00D
- • Patients who do not provide informed consent
- • Patients who do not understand the study procedure
- • Previous corneal surgery or trauma
- • Irregular cornea (e.g. keratoconus)
- • Choroidal hemorrhage
- • Microphtalmos
- • Severe corneal dystrophy
- • Uncontrolled or medically controlled glaucoma
- • Clinically significant macular changes
- • Concomitant severe eye disease
- • Non-age-related cataract
- • Severe optic nerve atrophy
- • Diabetic retinopathy
- • Proliferative diabetic retinopathy
- • Amblyopia
- • Extremely shallow anterior camera
- • Severe chronic uveítis
- • Pregnant or nursing
- • Rubella
- • Mature/dense cataract that makes it difficult to examine the fundus preoperatively.
- • Previous retinal detachment
- • Concurrent participation in other research with drugs or clinical devices
- • Expect to require another eye surgery during the study period
About Ast Products, Inc.
AST Products, Inc. is a leading clinical trial sponsor dedicated to advancing innovative medical solutions through rigorous research and development. With a focus on enhancing patient care, the company specializes in the design and execution of clinical trials that evaluate the safety and efficacy of cutting-edge therapeutic products. Leveraging a team of experienced professionals and robust methodologies, AST Products, Inc. is committed to adhering to the highest regulatory standards while fostering collaboration with healthcare providers and research institutions. Their mission is to bring transformative healthcare solutions to market, ultimately improving outcomes for patients globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alicante, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported